Kopf- und Gesichtsschmerzen

  • R.F. Schmidt
  • H.D. Langohr
  • J.M. Klotz
  • P. Berlit


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


Zitierte Literatur

  1. Achkar AA, Lie JT, Hunder GG, O’Fallon WM, Gabriel SE (1994) How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 120: 987–992PubMedGoogle Scholar
  2. Andres KH, v. Düring M, Muszinski K, Schmidt RF (1987a) The innervation of the dura mater encephali of the rat. In: Schmidt RF, Schaible H-G, Vahle-Hinz C (eds) Fine afferent nerve fibers and pain. VCH, WeinheimGoogle Scholar
  3. Andres KH, v. Düring M, Muszinski K, Schmidt RF (1987b) Nerve fibers and their terminals of the dura mater encephali of the rat. Anat Embryol 175: 289–301CrossRefPubMedGoogle Scholar
  4. Antonaci F, Sjaastad O (1989) Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations. Headache 29: 648–656CrossRefPubMedGoogle Scholar
  5. Berlit P (1992) Clinical and laboratory findings with giant-cell-arteritis. J Neurol Sci 111: 1–12CrossRefPubMedGoogle Scholar
  6. Berlit P (1998) Basiswissen Neurologie, 3. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  7. Birbaumer N, Schmidt RF (2003) Biologische Psychologie, 5. Aufl. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  8. Blau JN (1980) Migraine prodromes separated from aura: complete migraine. Br Med J 281: 658–660PubMedGoogle Scholar
  9. Bromm B, Desmedt J (eds) (1995) Pain and the brain: From nociception to cognition. Raven, New YorkGoogle Scholar
  10. Burstein R, Jakubowski M (2004) Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol 55: 27–36PubMedGoogle Scholar
  11. Buzzi MG, Moskowitz MA (1990) The antimigraine drug sumatriptan (GR43175), selectively blocks neurogenic extravasation from blood vessels in dura mater. Br J Pharmacol 99: 202–206PubMedGoogle Scholar
  12. Buzzi MG, Moskowitz MA (1992) The trigeminovascular system and migraine. Pathol Biol Paris 40: 313–317PubMedGoogle Scholar
  13. Carlsson A, Forsgren L, Nylander PO, Hellmann U, Forsman-Semb K, Holmgren G, Holmberg D, Holmber M (2002) Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1. Neurology 59: 1804–1807PubMedGoogle Scholar
  14. Carrera P, Stenirri S, Ferrari M, Battistini S (2001) Familial hemiplegic migraine: a ion channel disorder. Brain Res Bull 56: 239–241CrossRefPubMedGoogle Scholar
  15. Carrie F, Roblot P, Bouquet S, Delon A, Roblot F, Becq-Giraudon B (1994). Rifampicin-induced nonresponsiveness of giant cell arteritis to prednisone treatment. Arch Intern Med 154: 1521–1524CrossRefPubMedGoogle Scholar
  16. Caselli RJ, Daube JR, Hunder GG, Whisnant JP (1988) Peripheral neuropathic syndromes in giant cell (temporal) arteritis. Neurology 38: 685–689PubMedGoogle Scholar
  17. Chapman KM, Szczygielski BI, Toth C et al. (2003) Pseudomigraine with lymphocytic pleocytosis: a calcium channelopathy? Clinical description of 10 cases and genetic analysis of the familial hemiplegic migraine gene CACNA1A. Headache 43: 892–895CrossRefPubMedGoogle Scholar
  18. Dalessio DJ (1993) Wolff’s headache and other head pain. Oxford Univ Press, New YorkGoogle Scholar
  19. De Silva M, Hazleman BL (1986) Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis 45: 136–138PubMedGoogle Scholar
  20. Delecoeuillerie G, Joly P, Cohen de Lara A, Paolaggi JB (1988) Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimen (11 year survey of 210 patients). Ann Rheum Dis 47: 733–739PubMedGoogle Scholar
  21. Denker PG (1944) The postconcussion syndrome. Prognosis and evaluation of the organic factors. NY State J Med 44: 379–384Google Scholar
  22. Diener HC, Goadsby PJ (1998) Die Behandlung der akuten Migräneattacke: Neues in der Kopfschmerzforschung. Akt Neurologie 25: 329–336Google Scholar
  23. Diener HC, Wilkinson M (eds) (1988) Drug induced headache. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  24. Diener HC, Rahlfs VW, Danesch U (2004) The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol 51: 89–97CrossRefPubMedGoogle Scholar
  25. Diener HC, Brune K, Evers S et al. (2005) Therapie der Migräneattacke und Migräneprophylaxe. Leitlinie der Deutschen Gesellschaft für Neurologie und der Deutschen Migräne und Kopfschmerzgesellschaft. Kopfschmerz-News 14: 1–50Google Scholar
  26. Diener HC, Pfaffenrath V, Pageler L et al. (2005) The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multi-centre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25Google Scholar
  27. Edvinsson L, Goadsby PJ (1998) Neuropeptides in headache. Europ J Neurol 5: 329–341Google Scholar
  28. Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW (2002) Treatment of headache with botulinum toxin A — a review according to evidence-based medicine criteria. Cephalalgia 22: 699–710PubMedGoogle Scholar
  29. Freitag FG, Collins SD, Carlson HA et al., ER Migraine Study Group (2002) A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology 58: 1652–1659PubMedGoogle Scholar
  30. Gardner K, Barmada MM, Ptacek LJ, Hoffman EP (1997) A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology 49: 1231–1238PubMedGoogle Scholar
  31. Generau T, Herson S, Pette JC et al. (1992) Temporal arteritis in young subjects. A trial of nosological classification apropos of 6 cases. Ann Med Interne (Paris) 143: 303–308Google Scholar
  32. Goadsby PB, Lipton RB, Ferrai MD (2002) Migraine: current understanding and management. N Engl J Med 346: 257–270CrossRefPubMedGoogle Scholar
  33. Göbel H, Petersen-Braun M, Soyka D (1994) The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia 14: 97–106PubMedGoogle Scholar
  34. Hammill JM, Cook TM, Rosecrance JC (1996) Effectiveness of a physical therapy regimen in the treatment of tension-type headache. Headache 36: 149–153CrossRefPubMedGoogle Scholar
  35. Handwerker HO (1999) Einführung in die Pathophysiologie des Schmerzes. Springer, BerlinGoogle Scholar
  36. Hernandez C, Fernandez B, Ramos P, Estrada V, Perez-Venegas J, Baoares A (1991) Giant cell arteritis therapy: methotrexate as steroid-sparing agent. Arthritis Rheum 34S: A43Google Scholar
  37. Hunder GG, Sheps SG, Allen GL, Joyce JW (1975) Daily and alternateday corticosteroid regimens in treatment of giant cell arteritis. Ann Int Med 82: 613–618PubMedGoogle Scholar
  38. Ickenstein GW, Klotz JM, Langohr HD (1999) Kopfschmerz bei Polycythaemia vera. Klassifikation eines Kopfschmerzes bei Stoffwechselstörungen. Schmerz 13: 279–282CrossRefPubMedGoogle Scholar
  39. Jensen R, Rasmussen BK (1996) Muscular disorders in tension-type headache. Cephalalgia 16: 97–103PubMedGoogle Scholar
  40. Joutel A, Vahedi K, Corpechot C et al. (1997) Strong clustering and stereotyped nature of notch 3 mutations in CADASIL patients. Lancet 350: 1511–1515CrossRefPubMedGoogle Scholar
  41. Kavuk I, Katsarava Z, Selekler M (2004) Clinical features and therapy of medication overuse headache. Eur J Med Res 22: 565–569Google Scholar
  42. Keidel M, Diener H-Ch (1997) Der posttraumatische Kopfschmerz. Nervenarzt 68: 769–777CrossRefPubMedGoogle Scholar
  43. Klotz JM (2004) Alter Patient mit neu aufgetretenem Kopfschmerz. MMW-Fortschr Med 40: 817–820Google Scholar
  44. Klotz JM, Heils A, Langohr HD (1992) Quantitative und topographische Analyse des Photic-Driving-Effektes bei Patienten mit Migräne. Nervenheilkunde 11: 316–322Google Scholar
  45. Kurth T, Slomke MA, Kase CS et al. (2005) Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 64: 1020–1026PubMedGoogle Scholar
  46. Lance JW (1981) Headache. Ann Neurol 10: 1–10CrossRefPubMedGoogle Scholar
  47. Lauritzen M, Hansen AJ (1988) Spreading depression of Leao. Possible relation to migraine pathophysiology. In: Olesen J, Edvinsson L (eds) Basic mechanisms of headache. Elsevier, Amsterdam, pp 439–446Google Scholar
  48. Leniger T, Pageler L, Stude P, Diener HC, Limmroth V (2005) Comparison of intravenous valproate with intravenous lysine-acetylsalicylic acid in acute migraine attacks. Headache 45: 42–46CrossRefPubMedGoogle Scholar
  49. Leone M, Franzini A, Broggi G, May A, Bussone G (2004) Long-term follow-up of bilateral hypothalamic stimulation for intractable cluster headache. Brain 127: 2259–2264CrossRefPubMedGoogle Scholar
  50. Linde K, Streng A, Jurgens S et al. (2005) Acupuncture for patients with migraine: a randomized controlled trial. JAMA 293: 2118–2125CrossRefPubMedGoogle Scholar
  51. Lipchik GL, Holroyd KA, Talbot F, Greer M (1997) Pericranial muscle tenderness and exteroceptive suppression of temporalis muscle activity: a blind study of chronic tension-type headache. Headache 37: 368–376CrossRefPubMedGoogle Scholar
  52. Lu SR, Fuh JL, Chen WT, Juang KD, Wang SJ (2001) Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 21: 980–986CrossRefPubMedGoogle Scholar
  53. Mathew NT, Stubits E, Nigam MR (1982) Transformation of episodic migraine into daily headache. Analysis of factors. Headache 22: 66–68PubMedGoogle Scholar
  54. May A, Ophoff RA, Terwindt GM et al. (1995) Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Human Genet 96: 604–608CrossRefGoogle Scholar
  55. May A, Bahra A, Buchel C, Frackowiak RSJ, Goadsby PJ (1998) Hypothalamic activation in cluster headache attacks. Lancet 351: 275–278Google Scholar
  56. Merskey MRH, Bogduk N (eds) (1994) Classification of chronic pain. International Association for the Study of Pain, SeattleGoogle Scholar
  57. Messlinger K, Hanesch U, Baumgärtel M, Trost B, Schmidt RF (1993) Innervation of the dura mater encephali of the cat and rat: ultrastructure and calcitonin gene-related peptide-like and substance P-like immmunoreactivity. Anat Embryol 188: 219–237PubMedGoogle Scholar
  58. Newman LC, Lipton RB, Solomon S (1993) Hemicrania continua: 7 new cases and a literature review. Headache 32: 237–238Google Scholar
  59. Olesen J, Schmidt RF (eds) (1993) Pathophysiological mechanisms of migraine. VCH, WeinheimGoogle Scholar
  60. Olesen J, Tfelt-Hansen P, Welch KMA (eds) (1993) The head aches. Raven, New YorkGoogle Scholar
  61. Olesen J, Bousser MG, Diener HC et al. (2004) The International Classification of Headache Disorders, 2nd edn. Cephalalgia 24(Suppl 1): 1–160Google Scholar
  62. Ophoff RA, Terwindt GM, Vergouwe MN et al. (1996) Familial hemiplegic migraine and episodic ataxie type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87: 543–552CrossRefPubMedGoogle Scholar
  63. Pfaffenrath V, Goes A (1996) Die medikamentöse Therapie der menstruellen Migräne. Schmerz 10: 146–148CrossRefPubMedGoogle Scholar
  64. Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH (2002) The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis — a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia 22: 523–532CrossRefPubMedGoogle Scholar
  65. Raskin NH (1988) The hypnic headache syndrome. Headache 28: 534–536PubMedGoogle Scholar
  66. Rasmussen BK, Jensen R, Schroll M, Olesen J (1991) Epidemiology of headache in a general population — a prevalence study. J Clin Epidemiol 44: 1147–1157CrossRefPubMedGoogle Scholar
  67. Russell MB, Olesen J (1996) A nosographic analysis of the migraine aura in a general population. Brain 119: 355–361PubMedGoogle Scholar
  68. Russell MB, Iselius L, Olesen J (1996) Migraine without aura and migraine with aura are inherited disorders. Cephalalgia 16: 305–309PubMedGoogle Scholar
  69. Säve-Söderbergh J, Malmvall BO, Andersson R, Bengtsson BA (1986) Giant cell arteritis as a cause of death. Report of nine cases. JAMA 255: 493–496PubMedGoogle Scholar
  70. Sato A, Sato Y, Schmidt RF (1997) The impact of somatosensory input on autonomic functions. Rev Physiol 130: 1–328Google Scholar
  71. Schmidt RF, Thews G, Lang F (Hrsg) (2000) Physiologie des Menschen, 28. Aufl. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  72. Schmidt WA, Kraft HE, Vorpahl K, Völker L, Gromnica-Ihle EJ (1997) Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 337: 1336–1342PubMedGoogle Scholar
  73. Schoenen J (1997) Acute migraine therapy: the newer drugs. Curr Opin Neurol 10: 237–243PubMedGoogle Scholar
  74. Schoenen J, Jamart B, Gerard P, Lenarduzzi P, Delwaide PJ (1987) Exteroceptive suppression of temporalis muscle activity in chronic headache. Neurology 37: 1834–1836PubMedGoogle Scholar
  75. Schulman E, Dermott K (2003) Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs. Headache 43: 729–733CrossRefPubMedGoogle Scholar
  76. Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group (2004) Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 61: 490–495CrossRefPubMedGoogle Scholar
  77. Sjaastad O (1992) Cluster headache syndrome. Saunders, LondonGoogle Scholar
  78. Sjaastad O, Dale I (1974) Evidence for a new (?), treatable headache entity. Headache 14: 105–108CrossRefPubMedGoogle Scholar
  79. Sjaastad O, Zhao JM, Kruszewski P, Stovner LJ (1991) Shortlasting, unilateral, neuralgiform headache attacks with conjunctival injection, tearing, etc (SUNCT): III. Another Norwegian case. Headache 31: 175–177CrossRefPubMedGoogle Scholar
  80. Soyka D (1990) Zervikogener Kopfschmerz. Nervenheilkunde 9: 265–267Google Scholar
  81. Stovner LJ, Sjaastad O (1995) Treatment of cluster headache and its variants. Curr Opin Neurol 8: 243–247PubMedGoogle Scholar
  82. Vanast PJ (1986) New daily persistent headaches: definition of a benign syndrome (abstract). Headache 26: 317Google Scholar
  83. Walach H, Lowes T, Mussbach D et al. (2000) The long-term effects of homeopathic treatment of chronic headaches: 1 year follow up. Cephalalgia 20: 835–837CrossRefPubMedGoogle Scholar
  84. Wallasch TM, Reinecke M, Langohr HD (1991) EMG analysis of the late exteroceptive suppression period of temporal muscle activity in episodic and chronic tension-type headaches. Cephalalgia 11: 109–112CrossRefPubMedGoogle Scholar
  85. Weiller C, May A, Limmroth V et al. (1995) Brain stem activation in spontaneous human migraine attacks. Nature Med 1: 658–660PubMedGoogle Scholar
  86. Wendling D, Hory B, Blanc D (1985) Cyclosporine: a new adjuvant therapy for giant cell arteritis? Arthritis Rheum 28: 1078–1079PubMedGoogle Scholar
  87. Zweegman S, Makkink B, Stehouwer CD (1993) Giant cell arteritis with normal erythrocyte sedimentation rate: case report and review of the literature. Neth J Med 42: 128–131PubMedGoogle Scholar

Weiterführende Literatur

  1. Belmonte C, Cervero F (eds) (1996) Neurobiology of nocicep tors. Oxford Univ Press, Oxford New York TokyoGoogle Scholar
  2. Berlit P (1997) Giant cell arteritis. In: Lechtenberg R, Schutta HS (eds) Practice guidelines for neurologic therapy. Dekker, New YorkGoogle Scholar
  3. Busch V, May A (2002) Kopf-und Gesichtsschmerzen. Das Praxisbuch. Urban & Fischer, MünchenGoogle Scholar
  4. Caselli RJ, Hunder GG (1993) Neurologic aspects of giant cell (temporal) arteritis. Rheum Dis Clin North Am 19: 941–953PubMedGoogle Scholar
  5. Diener HC (ed) (2000) Drug treatment of migraine and other headaches. Karger, BaselGoogle Scholar
  6. Diener HC (2002) Kopf-und Gesichtsschmerzen. Diagnose und Behandlung in der Praxis, 2. Aufl. Thieme, StuttgartGoogle Scholar
  7. Diener HC (Hrsg) (2003) Kopfschmerzen. Thieme, StuttgartGoogle Scholar
  8. Diener HC, Hacke W (Hrsg) für die Kommission „Leitlinien“ der Deutschen Gesellschaft für Neurologie (2005) Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, StuttgartGoogle Scholar
  9. Diener HC, Eikermann A, Pageler L (2005) Migräne. Fortschr Neurol Psychiatr 73: 44–59CrossRefPubMedGoogle Scholar
  10. Dudel J, Menzel R, Schmidt RF (Hrsg) (2001) Neurowissenschaft — Vom Molekül zur Kognition. 2. Aufl. Springer, Berlin Göttingen Heidelberg New YorkGoogle Scholar
  11. Eccles JC (1964) The physiology of synapses. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  12. Evers S, Göbel H, Heinze A, Heinze-Kuhn K (2003) Kopfschmerzklassifikationskomitee der International Headache Society. Die Internationale Klassifikation von Kopfschmerzen, 2. Aufl. Nervenheilkunde 22: 531–670Google Scholar
  13. Fölsch UR, Kochsiek K, Schmidt RF (Hrsg) (2000) Pathophysiologie. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  14. Göbel H (1997) Die Kopfschmerzen. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  15. Göbel H, Diener HC, Grotemeyer KH, Pfaffenrath V (1997) Therapie des Clusterkopfschmerzes. Therapieempfehlungen der Deutschen Migräne-und Kopfschmerzgesellschaft. Nervenheilkunde 16: 548–557Google Scholar
  16. Handwerker H, Kobal G (1993) Psychophysiology of experimentally induced pain. Physiol Rev 73: 639–671PubMedGoogle Scholar
  17. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain (1988). Cephalalgia 8Suppl. 7: 1–96Google Scholar
  18. Hierholzer K, Schmidt RF (Hrsg) (1991) Pathophysiologie des Menschen. VCH, WeinheimGoogle Scholar
  19. Hökfelt T, Schaible H-G, Schmidt RF (eds) (1994) Neuro peptides, Nociception and Pain. Chapman & Hall, WeinheimGoogle Scholar
  20. Hunder GG, Weyand CM (1997) Sonography in giant-cell arteritis. N Engl J Med 337: 1385–1386CrossRefPubMedGoogle Scholar
  21. Huston KA, Hunder GG (1980) Giant cell (cranial) arteritis: a clinical review. Am Heart J 100: 99–107CrossRefPubMedGoogle Scholar
  22. Imakita M, Yutani C, Ishibashi-Ueda H (1993) Giant cell arteritis involving the cerebral arteries. Arch Pathol Lab Med 117: 729–733PubMedGoogle Scholar
  23. Jänig W, Schmidt RF (eds) (1992) Reflex sympathetic dystrophy. Pathophysiological mechanisms and clinical implications. VCH, WeinheimGoogle Scholar
  24. Langohr HD, Keidel M, Göbel H, Baar T, Wallasch TM (1995) Kopfschmerz nach Schädel-Hirn-Trauma und HWS-Distorsion: Diagnose und Therapie. Münch Med Wochenschr 32/33: 35–40Google Scholar
  25. Liozon F, Vidal E, Gaches F et al. (1992) Death in Horton disease. Prognostic factors. Rev Med Interne 13: 187–191PubMedGoogle Scholar
  26. Penfield W, Rasmussen T (1950) The cerebral cortex of man. Macmillan, New YorkGoogle Scholar
  27. Pfaffenrath V, Brune K, Diener HC, Gerber WD, Göbel H (2000) Die Behandlung des Kopfschmerzes vom Spannungstyp. Empfehlungen der Deutschen Migräne-und Kopfschmerzgesellschaft. Nervenheilkunde 19: 335–345Google Scholar
  28. Pfaffenrath V, Gerber WD (2000) Chronische Kopfschmerzen. Kohlhammer, StuttgartGoogle Scholar
  29. Schmidt RF (2001) Physiologie kompakt, 4. Aufl. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  30. Schmidt RF, Schaible H-G (Hrsg) (2006) Neuro-und Sinnesphysiologie, 5. Aufl. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  31. Turnbull J (1996) Temporal arteritis and polymyalgia rheumatica: Nosographic and nosologic considerations. Neurology 46: 901–906PubMedGoogle Scholar
  32. Wall PD, Melzack R (eds) (1994) Textbook of pain, 3rd edn. Churchill Livingstone, EdinburghGoogle Scholar
  33. Wessely P (2000) Praktischer Umgang mit Kopf-und Gesichtsschmerzen. Systematik, Aetiologie und Therapie. Springer, WienGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2006

Authors and Affiliations

  • R.F. Schmidt
    • 1
  • H.D. Langohr
    • 2
  • J.M. Klotz
    • 2
  • P. Berlit
    • 3
  1. 1.Physiologisches Institut der Universität WürzburgWürzburg
  2. 2.Klinik für Neurologie und NeurophysiologieStädtisches Klinikum FuldaFulda
  3. 3.Klinik für Neurologie mit Klinischer NeurophysiologieAlfried Krupp KrankenhausEssen

Personalised recommendations